Annual D&A
$3.26B$408.14M+14.31%
Summary
- Current Value
- As of today, GSK annual D&A is $3.26B, up +14.31% on
- Historical Performance
- GSK annual D&A is up +11.69% over the past 3 years, and up +9.47% over the past 5 years
- All-Time High Comparison
- GSK annual D&A is currently at its all-time high
- 3-Year Low Comparison
- GSK annual D&A is +23.26% above its 3-year low of $2.64B reached on an earlier date
- Sector Comparison
- GSK annual D&A is higher than 98.84% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $3.26B | +14.3% | +11.7% | +9.5% | +33.0% | |
| Quarterly D&A | $1.05B | -13.6% | -8.8% | +29.6% | +18.9% | |
| TTM D&A | $4.75B | +14.6% | +45.0% | +850.7% | +69.7% | |
| Price | $47.77 | +42.9% | +35.0% | +23.2% | +26.4% | |
| Annual SG&A | $253.01M | +2.3% | +8.8% | -49.5% | -98.3% | |
| Annual Total Expenses | $34.96B | +22.3% | +28.2% | -0.3% | +11.9% | |
| Annual Operating Expenses | $23.40B | +30.4% | +45.9% | +17.5% | +18.9% | |
| Annual Revenue | $40.09B | +6.3% | +18.0% | -6.9% | -9.9% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.26B | at high | |
| 5Y | $3.26B | at high | |
| All | $3.26B | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.64B | N/A | +23.3% |
| 5Y | $2.64B | +23.3% | |
| All | $279.40M | +1066.7% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of GSK?
As of today, GSK annual D&A is $3.26B
What is 1-year change in GSK annual D&A?
GSK annual D&A is up +14.31% year-over-year
What is 3-year change in GSK annual D&A?
GSK annual D&A is up +11.69% over the past 3 years
How far is GSK annual D&A from its all-time high?
GSK annual D&A is currently at its all-time high
How does GSK annual D&A rank versus sector peers?
GSK annual D&A is higher than 98.84% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly D&A
$1.05B$478.88M-31.39%
Summary
- Current Value
- As of today, GSK quarterly D&A is $1.05B, down -31.39% on
- Historical Performance
- GSK quarterly D&A is down -13.61% year-over-year, and down -8.79% over the past 3 years
- All-Time High Comparison
- GSK quarterly D&A is currently -69.47% below its historical high of $3.43B set on
- 3-Year Low Comparison
- GSK quarterly D&A is +1502.01% above its 3-year low of -$74.64M reached on an earlier date
- Sector Comparison
- GSK quarterly D&A is higher than 98.93% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $1.05B | -31.4% | -13.6% | -8.8% | +29.6% | |
| Annual D&A | $3.26B | – | +14.3% | +11.7% | +9.5% | |
| TTM D&A | $4.75B | -3.4% | +14.6% | +45.0% | +850.7% | |
| Price | $47.77 | +8.3% | +42.9% | +35.0% | +23.2% | |
| Quarterly SG&A | $3.02B | +5.6% | -38.9% | +24.9% | -12.4% | |
| Quarterly Total Expenses | $8.81B | +0.8% | -16.0% | +6.0% | -7.8% | |
| Quarterly Operating Expenses | $5.04B | -8.2% | -25.6% | +29.4% | +7.3% | |
| Quarterly Revenue | $11.52B | +8.0% | +10.6% | +25.2% | +3.2% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.53B | -31.4% | |
| 3Y | $1.53B | -31.4% | |
| 5Y | $3.43B | N/A | -69.5% |
| All | $3.43B | -69.5% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.04B | +1.0% | |
| 3Y | -$74.64M | N/A | +1502.0% |
| 5Y | -$74.64M | +1502.0% | |
| All | -$1.47B | +171.2% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of GSK?
As of today, GSK quarterly D&A is $1.05B
What is GSK quarterly D&A most recent change?
GSK quarterly D&A was down -31.39% on September 1, 2025
What is 1-year change in GSK quarterly D&A?
GSK quarterly D&A is down -13.61% year-over-year
How far is GSK quarterly D&A from its all-time high?
GSK quarterly D&A is currently -69.47% below its historical high of $3.43B set on December 31, 2020
How does GSK quarterly D&A rank versus sector peers?
GSK quarterly D&A is higher than 98.93% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM D&A
$4.75B$164.88M-3.36%
Summary
- Current Value
- As of today, GSK TTM D&A is $4.75B, down -3.36% on
- Historical Performance
- GSK TTM D&A is up +14.61% year-over-year, and up +44.99% over the past 3 years
- All-Time High Comparison
- GSK TTM D&A is currently -20.22% below its historical high of $5.95B set on
- 3-Year Low Comparison
- GSK TTM D&A is +134.92% above its 3-year low of $2.02B reached on
- Sector Comparison
- GSK TTM D&A is higher than 99.22% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $4.75B | -3.4% | +14.6% | +45.0% | +850.7% | |
| Annual D&A | $3.26B | – | +14.3% | +11.7% | +9.5% | |
| Quarterly D&A | $1.05B | -31.4% | -13.6% | -8.8% | +29.6% | |
| Price | $47.77 | +8.3% | +42.9% | +35.0% | +23.2% | |
| TTM SG&A | $46.02B | +233.1% | +228.3% | +342.8% | +207.5% | |
| TTM Revenue | $42.06B | +2.7% | +6.0% | +13.4% | -3.7% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.91B | -3.4% | |
| 3Y | $4.91B | -3.4% | |
| 5Y | $5.95B | -20.2% | |
| All | $5.95B | -20.2% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.85B | N/A | +23.3% |
| 3Y | $2.02B | +134.9% | |
| 5Y | $2.02B | +134.9% | |
| All | -$826.51M | +674.4% |
TTM D&A History
FAQ
What is the current TTM D&A of GSK?
As of today, GSK TTM D&A is $4.75B
What is GSK TTM D&A most recent change?
GSK TTM D&A was down -3.36% on September 1, 2025
What is 1-year change in GSK TTM D&A?
GSK TTM D&A is up +14.61% year-over-year
How far is GSK TTM D&A from its all-time high?
GSK TTM D&A is currently -20.22% below its historical high of $5.95B set on September 30, 2021
How does GSK TTM D&A rank versus sector peers?
GSK TTM D&A is higher than 99.22% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk